| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |